NEW YORK (GenomeWeb News) – Indian biotech services company Jubilant Biosys has entered a co-marketing agreement with DiscoveRx to screen potential drug compounds, Jubilant said yesterday.

The agreement will enable Jubilant’s pharmaceutical customers to use DiscoveRx services such as the PathHunter and CampHunter cell lines and chemiluminescent detection technology.

The agreement will also allow DiscoveRx to offer screening solutions from India, Jubilant said.

Jubilant Biosys, based in Noida with facilities in Bangalore, is a subsidiary of Jubilant Organsys.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.